A Practical Guide to Establishing a Molecular-Based Point-of-Care Testing Network for Chlamydia Article Swipe
Mark Shephard
,
Susan Matthews
,
Kelly Andrewartha
,
Gabi Hewer
,
Kirsty Smith
,
Louise Causer
,
Rebecca Guy
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.5772/intechopen.1007789
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.5772/intechopen.1007789
This chapter provides a ‘how to guide’ to set up and manage a molecular-based point-of-care (POC) testing network to detect Chlamydia trachomatis (Chlamydia) in populations experiencing high burden of infection and sequelae as well as barriers to accessing routine laboratory services. The chapter outlines the experience of the Australian-based Test, Treat and Go (TTANGO) program which, to the authors’ knowledge, represents the largest decentralised POC testing network for chlamydia (as well as gonorrhoea and trichomoniasis) in the primary care sector globally. The chapter provides an overview of the program’s evolution from a randomised controlled trial through implementation, translation, and scale-up phases to a now national routine program with associated testing rebates. The chapter will examine the governance, training and quality management, and connectivity processes that underpin the TTANGO network and describe the clinical, cultural, operational and economic effectiveness of the network. Collectively, these elements provide a template for translation to low- and middle-income countries (LMIC) where Chlamydia trachomatis remains a significant contemporary health problem.
Related Topics
Concepts
Metadata
- Type
- book-chapter
- Language
- en
- Landing Page
- https://doi.org/10.5772/intechopen.1007789
- https://www.intechopen.com/citation-pdf-url/1200105
- OA Status
- hybrid
- References
- 36
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4405732925
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4405732925Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.5772/intechopen.1007789Digital Object Identifier
- Title
-
A Practical Guide to Establishing a Molecular-Based Point-of-Care Testing Network for ChlamydiaWork title
- Type
-
book-chapterOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-12-24Full publication date if available
- Authors
-
Mark Shephard, Susan Matthews, Kelly Andrewartha, Gabi Hewer, Kirsty Smith, Louise Causer, Rebecca GuyList of authors in order
- Landing page
-
https://doi.org/10.5772/intechopen.1007789Publisher landing page
- PDF URL
-
https://www.intechopen.com/citation-pdf-url/1200105Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://www.intechopen.com/citation-pdf-url/1200105Direct OA link when available
- Concepts
-
Chlamydia trachomatis, Point-of-care testing, Chlamydia, Medicine, Gynecology, Pathology, ImmunologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
36Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4405732925 |
|---|---|
| doi | https://doi.org/10.5772/intechopen.1007789 |
| ids.doi | https://doi.org/10.5772/intechopen.1007789 |
| ids.openalex | https://openalex.org/W4405732925 |
| fwci | 0.0 |
| type | book-chapter |
| title | A Practical Guide to Establishing a Molecular-Based Point-of-Care Testing Network for Chlamydia |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10428 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2404 |
| topics[0].subfield.display_name | Microbiology |
| topics[0].display_name | Reproductive tract infections research |
| topics[1].id | https://openalex.org/T11934 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.98580002784729 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2737 |
| topics[1].subfield.display_name | Physiology |
| topics[1].display_name | Syphilis Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T10327 |
| topics[2].field.id | https://openalex.org/fields/36 |
| topics[2].field.display_name | Health Professions |
| topics[2].score | 0.983299970626831 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3600 |
| topics[2].subfield.display_name | General Health Professions |
| topics[2].display_name | Adolescent Sexual and Reproductive Health |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777391075 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7299931645393372 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q131065 |
| concepts[0].display_name | Chlamydia trachomatis |
| concepts[1].id | https://openalex.org/C64841741 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6422243118286133 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q491983 |
| concepts[1].display_name | Point-of-care testing |
| concepts[2].id | https://openalex.org/C2780122209 |
| concepts[2].level | 2 |
| concepts[2].score | 0.630990743637085 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q153356 |
| concepts[2].display_name | Chlamydia |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.4707147479057312 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C29456083 |
| concepts[4].level | 1 |
| concepts[4].score | 0.26004377007484436 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1221899 |
| concepts[4].display_name | Gynecology |
| concepts[5].id | https://openalex.org/C142724271 |
| concepts[5].level | 1 |
| concepts[5].score | 0.14438089728355408 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[5].display_name | Pathology |
| concepts[6].id | https://openalex.org/C203014093 |
| concepts[6].level | 1 |
| concepts[6].score | 0.1269732117652893 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[6].display_name | Immunology |
| keywords[0].id | https://openalex.org/keywords/chlamydia-trachomatis |
| keywords[0].score | 0.7299931645393372 |
| keywords[0].display_name | Chlamydia trachomatis |
| keywords[1].id | https://openalex.org/keywords/point-of-care-testing |
| keywords[1].score | 0.6422243118286133 |
| keywords[1].display_name | Point-of-care testing |
| keywords[2].id | https://openalex.org/keywords/chlamydia |
| keywords[2].score | 0.630990743637085 |
| keywords[2].display_name | Chlamydia |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.4707147479057312 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/gynecology |
| keywords[4].score | 0.26004377007484436 |
| keywords[4].display_name | Gynecology |
| keywords[5].id | https://openalex.org/keywords/pathology |
| keywords[5].score | 0.14438089728355408 |
| keywords[5].display_name | Pathology |
| keywords[6].id | https://openalex.org/keywords/immunology |
| keywords[6].score | 0.1269732117652893 |
| keywords[6].display_name | Immunology |
| language | en |
| locations[0].id | doi:10.5772/intechopen.1007789 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306463448 |
| locations[0].source.issn | |
| locations[0].source.type | ebook platform |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | IntechOpen eBooks |
| locations[0].source.host_organization | https://openalex.org/P4310322558 |
| locations[0].source.host_organization_name | IntechOpen |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310322558 |
| locations[0].source.host_organization_lineage_names | IntechOpen |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.intechopen.com/citation-pdf-url/1200105 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | book-chapter |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Molecular Diagnostics - Current Approaches and Their Clinical Applications |
| locations[0].landing_page_url | https://doi.org/10.5772/intechopen.1007789 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5071389494 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9181-1874 |
| authorships[0].author.display_name | Mark Shephard |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mark Shephard |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5070536805 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6824-4528 |
| authorships[1].author.display_name | Susan Matthews |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Susan Matthews |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5005583030 |
| authorships[2].author.orcid | https://orcid.org/0009-0006-3182-7280 |
| authorships[2].author.display_name | Kelly Andrewartha |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Kelly Andrewartha |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5115624012 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Gabi Hewer |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Gabi Hewer |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5103037098 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2637-3561 |
| authorships[4].author.display_name | Kirsty Smith |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Kirsty Smith |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5075423151 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-8814-0678 |
| authorships[5].author.display_name | Louise Causer |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Louise Causer |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5108942508 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Rebecca Guy |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Rebecca Guy |
| authorships[6].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.intechopen.com/citation-pdf-url/1200105 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | A Practical Guide to Establishing a Molecular-Based Point-of-Care Testing Network for Chlamydia |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10428 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2404 |
| primary_topic.subfield.display_name | Microbiology |
| primary_topic.display_name | Reproductive tract infections research |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W1983396513, https://openalex.org/W1949477813, https://openalex.org/W2028096858 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.5772/intechopen.1007789 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306463448 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | ebook platform |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | IntechOpen eBooks |
| best_oa_location.source.host_organization | https://openalex.org/P4310322558 |
| best_oa_location.source.host_organization_name | IntechOpen |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310322558 |
| best_oa_location.source.host_organization_lineage_names | IntechOpen |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.intechopen.com/citation-pdf-url/1200105 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | book-chapter |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Molecular Diagnostics - Current Approaches and Their Clinical Applications |
| best_oa_location.landing_page_url | https://doi.org/10.5772/intechopen.1007789 |
| primary_location.id | doi:10.5772/intechopen.1007789 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306463448 |
| primary_location.source.issn | |
| primary_location.source.type | ebook platform |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | IntechOpen eBooks |
| primary_location.source.host_organization | https://openalex.org/P4310322558 |
| primary_location.source.host_organization_name | IntechOpen |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310322558 |
| primary_location.source.host_organization_lineage_names | IntechOpen |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.intechopen.com/citation-pdf-url/1200105 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | book-chapter |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Molecular Diagnostics - Current Approaches and Their Clinical Applications |
| primary_location.landing_page_url | https://doi.org/10.5772/intechopen.1007789 |
| publication_date | 2024-12-24 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4392770404, https://openalex.org/W4392373994, https://openalex.org/W2105966733, https://openalex.org/W4200547015, https://openalex.org/W2331567076, https://openalex.org/W2610647956, https://openalex.org/W2399980544, https://openalex.org/W4321222394, https://openalex.org/W4388941699, https://openalex.org/W3093490744, https://openalex.org/W2462318335, https://openalex.org/W2901655212, https://openalex.org/W3207101243, https://openalex.org/W2806503337, https://openalex.org/W2157614997, https://openalex.org/W2802130137, https://openalex.org/W2894251822, https://openalex.org/W2198533860, https://openalex.org/W2291275930, https://openalex.org/W2782726954, https://openalex.org/W4385146861, https://openalex.org/W4399584346, https://openalex.org/W3213411920, https://openalex.org/W2790252021, https://openalex.org/W3117710527, https://openalex.org/W4406939146, https://openalex.org/W2765548883, https://openalex.org/W2416692400, https://openalex.org/W4384078785, https://openalex.org/W2911602704, https://openalex.org/W2743604568, https://openalex.org/W2941048908, https://openalex.org/W2695613910, https://openalex.org/W4220683916, https://openalex.org/W4387950411, https://openalex.org/W3156722612 |
| referenced_works_count | 36 |
| abstract_inverted_index.a | 3, 12, 91, 102, 145, 159 |
| abstract_inverted_index.Go | 52 |
| abstract_inverted_index.an | 84 |
| abstract_inverted_index.as | 32, 34, 71 |
| abstract_inverted_index.in | 23, 75 |
| abstract_inverted_index.of | 28, 46, 86, 138 |
| abstract_inverted_index.to | 5, 7, 18, 36, 56, 101, 149 |
| abstract_inverted_index.up | 9 |
| abstract_inverted_index.(as | 69 |
| abstract_inverted_index.POC | 64 |
| abstract_inverted_index.The | 41, 81, 111 |
| abstract_inverted_index.and | 10, 30, 51, 73, 98, 118, 121, 129, 135, 151 |
| abstract_inverted_index.for | 67, 147 |
| abstract_inverted_index.now | 103 |
| abstract_inverted_index.set | 8 |
| abstract_inverted_index.the | 44, 47, 57, 61, 76, 87, 115, 126, 131, 139 |
| abstract_inverted_index.This | 0 |
| abstract_inverted_index.care | 78 |
| abstract_inverted_index.from | 90 |
| abstract_inverted_index.high | 26 |
| abstract_inverted_index.low- | 150 |
| abstract_inverted_index.that | 124 |
| abstract_inverted_index.well | 33, 70 |
| abstract_inverted_index.will | 113 |
| abstract_inverted_index.with | 107 |
| abstract_inverted_index.(POC) | 15 |
| abstract_inverted_index.Test, | 49 |
| abstract_inverted_index.Treat | 50 |
| abstract_inverted_index.these | 142 |
| abstract_inverted_index.trial | 94 |
| abstract_inverted_index.where | 155 |
| abstract_inverted_index.(LMIC) | 154 |
| abstract_inverted_index.TTANGO | 127 |
| abstract_inverted_index.burden | 27 |
| abstract_inverted_index.detect | 19 |
| abstract_inverted_index.health | 162 |
| abstract_inverted_index.manage | 11 |
| abstract_inverted_index.phases | 100 |
| abstract_inverted_index.sector | 79 |
| abstract_inverted_index.which, | 55 |
| abstract_inverted_index.‘how | 4 |
| abstract_inverted_index.chapter | 1, 42, 82, 112 |
| abstract_inverted_index.examine | 114 |
| abstract_inverted_index.largest | 62 |
| abstract_inverted_index.network | 17, 66, 128 |
| abstract_inverted_index.primary | 77 |
| abstract_inverted_index.program | 54, 106 |
| abstract_inverted_index.provide | 144 |
| abstract_inverted_index.quality | 119 |
| abstract_inverted_index.remains | 158 |
| abstract_inverted_index.routine | 38, 105 |
| abstract_inverted_index.testing | 16, 65, 109 |
| abstract_inverted_index.through | 95 |
| abstract_inverted_index.(TTANGO) | 53 |
| abstract_inverted_index.barriers | 35 |
| abstract_inverted_index.describe | 130 |
| abstract_inverted_index.economic | 136 |
| abstract_inverted_index.elements | 143 |
| abstract_inverted_index.guide’ | 6 |
| abstract_inverted_index.national | 104 |
| abstract_inverted_index.network. | 140 |
| abstract_inverted_index.outlines | 43 |
| abstract_inverted_index.overview | 85 |
| abstract_inverted_index.problem. | 163 |
| abstract_inverted_index.provides | 2, 83 |
| abstract_inverted_index.rebates. | 110 |
| abstract_inverted_index.scale-up | 99 |
| abstract_inverted_index.sequelae | 31 |
| abstract_inverted_index.template | 146 |
| abstract_inverted_index.training | 117 |
| abstract_inverted_index.underpin | 125 |
| abstract_inverted_index.Chlamydia | 20, 156 |
| abstract_inverted_index.accessing | 37 |
| abstract_inverted_index.chlamydia | 68 |
| abstract_inverted_index.clinical, | 132 |
| abstract_inverted_index.countries | 153 |
| abstract_inverted_index.cultural, | 133 |
| abstract_inverted_index.evolution | 89 |
| abstract_inverted_index.globally. | 80 |
| abstract_inverted_index.infection | 29 |
| abstract_inverted_index.processes | 123 |
| abstract_inverted_index.services. | 40 |
| abstract_inverted_index.associated | 108 |
| abstract_inverted_index.authors’ | 58 |
| abstract_inverted_index.controlled | 93 |
| abstract_inverted_index.experience | 45 |
| abstract_inverted_index.gonorrhoea | 72 |
| abstract_inverted_index.knowledge, | 59 |
| abstract_inverted_index.laboratory | 39 |
| abstract_inverted_index.randomised | 92 |
| abstract_inverted_index.represents | 60 |
| abstract_inverted_index.(Chlamydia) | 22 |
| abstract_inverted_index.governance, | 116 |
| abstract_inverted_index.management, | 120 |
| abstract_inverted_index.operational | 134 |
| abstract_inverted_index.populations | 24 |
| abstract_inverted_index.program’s | 88 |
| abstract_inverted_index.significant | 160 |
| abstract_inverted_index.trachomatis | 21, 157 |
| abstract_inverted_index.translation | 148 |
| abstract_inverted_index.connectivity | 122 |
| abstract_inverted_index.contemporary | 161 |
| abstract_inverted_index.experiencing | 25 |
| abstract_inverted_index.translation, | 97 |
| abstract_inverted_index.Collectively, | 141 |
| abstract_inverted_index.decentralised | 63 |
| abstract_inverted_index.effectiveness | 137 |
| abstract_inverted_index.middle-income | 152 |
| abstract_inverted_index.point-of-care | 14 |
| abstract_inverted_index.implementation, | 96 |
| abstract_inverted_index.molecular-based | 13 |
| abstract_inverted_index.trichomoniasis) | 74 |
| abstract_inverted_index.Australian-based | 48 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 7 |
| citation_normalized_percentile.value | 0.65846995 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |